Instil Bio Inc.

01/14/2025 | Press release | Distributed by Public on 01/14/2025 06:18

Instil Bio Announces Clinical Progress in China for IMM2510/SYN 2510, a Clinical Stage PD L1xVEGF Bispecific Antibody